In Parkinson’s disease (PD), dopaminergic medication modulates behavioral and electrocortical markers of interpersonal performance monitoring, the ability to monitor and adapt to others actions, with implications for understanding and treating PD.
- Vanessa Era
- Ugo Giulio Pesci
- Salvatore Maria Aglioti
